SDTM

SDTM

  1. Feb 28, 2025

What Does the ‘SDTM’ Mean?

SDTM stands for Study Data Tabulation Model. It is a standard structure for submitting clinical trial data to regulatory authorities, developed by the Clinical Data Interchange Standards Consortium (CDISC).

SDTM provides a consistent framework for organizing and formatting clinical study data. This standardization facilitates data review, analysis, and sharing among different stakeholders in the clinical research process, including sponsors, contract research organizations, and regulatory agencies.

Why Is the ‘SDTM’ Important in Clinical Research?

SDTM is crucial in clinical research as it ensures data consistency and comparability across studies. By providing a standardized format, it streamlines the regulatory submission process, reducing time and resources required for data preparation and review.

The implementation of SDTM enhances data quality and facilitates more efficient analysis. It also promotes data transparency and enables easier integration of data from multiple sources, supporting meta-analyses and the development of larger, more comprehensive datasets for research purposes.

Good Practices and Procedures

  1. Develop and maintain a comprehensive SDTM Implementation Guide (IG) tailored to your organization’s specific needs and study designs.
  2. Implement automated data validation checks to ensure SDTM compliance throughout the data collection and processing stages.
  3. Conduct regular training sessions for data managers and statisticians on SDTM updates and best practices.
  4. Establish a cross-functional SDTM review process involving data managers, biostatisticians, and medical writers to ensure data integrity and consistency.
  5. Create and maintain a library of SDTM-compliant controlled terminologies and codelists to ensure standardization across studies.

Related Terms

Resources

Large Language Models in Nuclear Cardiology: From Experimental Tools to Clinical Infrastructure

3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…

From Half-Life to Clinical Impact: Mastering Time-Critical Supply Chains

How Axcellant helped a diagnostic study overcome isotope supply, manufacturing, and logistics constraints In radiopharmaceutical development, we often say that…

How ACT EU Is Forcing a Global Approach to Trial Timelines

Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…